CellSpring has developed a bioadhesion platform, dubbed QuickStick, that enables the formation of 3D, cellular microtissues in a rapid and cell-friendly chemical reaction. These microtissues promise to be the fastest forming, most reliable 3D tissues on the market for drug candidate screening.